Tailored Tumor Immunogenicity Reveals Regulation of CD4 and CD8 T Cell Responses against Cancer
Authors:
Open Access
- 1 November 2016
- journal article
- Published by Elsevier in Cell Reports
- Vol. 17 (9) , 2234-2246
Abstract
No abstract availableKeywords
Funding Information
- Deutsche Forschungsgemeinschaft [DFG] (WO 1933/1-1, WO 1933/1-2)
This publication has 33 references indexed in Scilit:
- Checkpoint blockade cancer immunotherapy targets tumour-specific mutant antigensNature, 2014
- Microsphere priming facilitates induction of potent therapeutic T‐cell immune responses against autochthonous liver cancersEuropean Journal of Immunology, 2013
- Tumor-specific CD4+ Melanoma Tumor-infiltrating LymphocytesJournal of Immunotherapy, 2012
- Exploiting the Mutanome for Tumor VaccinationCancer Research, 2012
- Expression of tumour-specific antigens underlies cancer immunoeditingNature, 2012
- Type, Density, and Location of Immune Cells Within Human Colorectal Tumors Predict Clinical OutcomeScience, 2006
- Somatic integration of an oncogene-harboring Sleeping Beauty transposon models liver tumor development in the mouseProceedings of the National Academy of Sciences, 2005
- The Three Es of Cancer ImmunoeditingAnnual Review of Immunology, 2004
- Tumor Suppression at the Mouse INK4a Locus Mediated by the Alternative Reading Frame Product p19Cell, 1997
- Tumorigenic transformation of mammalian cells induced by a normal human gene homologous to the oncogene of Harvey murine sarcoma virusNature, 1982